X-48689450-C-T

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBS1BS2

The NM_000377.3(WAS):​c.1453+16C>T variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00147 in 1,188,626 control chromosomes in the GnomAD database, including 1 homozygotes. There are 522 hemizygotes in GnomAD. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).

Frequency

Genomes: 𝑓 0.0012 ( 1 hom., 28 hem., cov: 23)
Exomes 𝑓: 0.0015 ( 0 hom. 494 hem. )

Consequence

WAS
NM_000377.3 intron

Scores

2

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts B:5

Conservation

PhyloP100: 0.332

Publications

0 publications found
Variant links:
Genes affected
WAS (HGNC:12731): (WASP actin nucleation promoting factor) The Wiskott-Aldrich syndrome (WAS) family of proteins share similar domain structure, and are involved in transduction of signals from receptors on the cell surface to the actin cytoskeleton. The presence of a number of different motifs suggests that they are regulated by a number of different stimuli, and interact with multiple proteins. Recent studies have demonstrated that these proteins, directly or indirectly, associate with the small GTPase, Cdc42, known to regulate formation of actin filaments, and the cytoskeletal organizing complex, Arp2/3. Wiskott-Aldrich syndrome is a rare, inherited, X-linked, recessive disease characterized by immune dysregulation and microthrombocytopenia, and is caused by mutations in the WAS gene. The WAS gene product is a cytoplasmic protein, expressed exclusively in hematopoietic cells, which show signalling and cytoskeletal abnormalities in WAS patients. A transcript variant arising as a result of alternative promoter usage, and containing a different 5' UTR sequence, has been described, however, its full-length nature is not known. [provided by RefSeq, Jul 2008]
WAS Gene-Disease associations (from GenCC):
  • Wiskott-Aldrich syndrome
    Inheritance: XL, AD Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Labcorp Genetics (formerly Invitae), ClinGen, Orphanet, Ambry Genetics
  • X-linked severe congenital neutropenia
    Inheritance: XL Classification: DEFINITIVE, STRONG, MODERATE, SUPPORTIVE Submitted by: Orphanet, ClinGen, Labcorp Genetics (formerly Invitae), Ambry Genetics
  • thrombocytopenia 1
    Inheritance: XL Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.88).
BP6
Variant X-48689450-C-T is Benign according to our data. Variant chrX-48689450-C-T is described in ClinVar as Benign/Likely_benign. ClinVar VariationId is 255962.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS1
Variant frequency is greater than expected in population nfe. GnomAd4 allele frequency = 0.00116 (129/110937) while in subpopulation NFE AF = 0.00193 (102/52929). AF 95% confidence interval is 0.00162. There are 1 homozygotes in GnomAd4. There are 28 alleles in the male GnomAd4 subpopulation. Median coverage is 23. This position passed quality control check.
BS2
High AC in GnomAd4 at 129 XL,AD gene.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_000377.3. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
WAS
NM_000377.3
MANE Select
c.1453+16C>T
intron
N/ANP_000368.1P42768
WAS
NM_001438877.1
c.1453+16C>T
intron
N/ANP_001425806.1
WAS
NM_001438878.1
c.1297+16C>T
intron
N/ANP_001425807.1

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
WAS
ENST00000376701.5
TSL:1 MANE Select
c.1453+16C>T
intron
N/AENSP00000365891.4P42768
WAS
ENST00000698635.1
c.1453+16C>T
intron
N/AENSP00000513850.1A0A8V8TM35
WAS
ENST00000698626.1
c.1453+16C>T
intron
N/AENSP00000513845.1A0A8V8TNH9

Frequencies

GnomAD3 genomes
AF:
0.00116
AC:
129
AN:
110882
Hom.:
1
Cov.:
23
show subpopulations
Gnomad AFR
AF:
0.000197
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00106
Gnomad ASJ
AF:
0.000757
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.000380
Gnomad FIN
AF:
0.000340
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.00193
Gnomad OTH
AF:
0.00335
GnomAD2 exomes
AF:
0.00145
AC:
230
AN:
158738
AF XY:
0.00155
show subpopulations
Gnomad AFR exome
AF:
0.000357
Gnomad AMR exome
AF:
0.00100
Gnomad ASJ exome
AF:
0.00144
Gnomad EAS exome
AF:
0.00113
Gnomad FIN exome
AF:
0.0000700
Gnomad NFE exome
AF:
0.00220
Gnomad OTH exome
AF:
0.00297
GnomAD4 exome
AF:
0.00151
AC:
1622
AN:
1077689
Hom.:
0
Cov.:
30
AF XY:
0.00143
AC XY:
494
AN XY:
345833
show subpopulations
African (AFR)
AF:
0.0000766
AC:
2
AN:
26117
American (AMR)
AF:
0.000893
AC:
30
AN:
33592
Ashkenazi Jewish (ASJ)
AF:
0.00105
AC:
20
AN:
19024
East Asian (EAS)
AF:
0.000402
AC:
12
AN:
29831
South Asian (SAS)
AF:
0.000481
AC:
25
AN:
51962
European-Finnish (FIN)
AF:
0.000176
AC:
7
AN:
39683
Middle Eastern (MID)
AF:
0.00955
AC:
39
AN:
4083
European-Non Finnish (NFE)
AF:
0.00169
AC:
1396
AN:
828017
Other (OTH)
AF:
0.00201
AC:
91
AN:
45380
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.493
Heterozygous variant carriers
0
58
116
174
232
290
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
46
92
138
184
230
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00116
AC:
129
AN:
110937
Hom.:
1
Cov.:
23
AF XY:
0.000844
AC XY:
28
AN XY:
33157
show subpopulations
African (AFR)
AF:
0.000197
AC:
6
AN:
30507
American (AMR)
AF:
0.00105
AC:
11
AN:
10436
Ashkenazi Jewish (ASJ)
AF:
0.000757
AC:
2
AN:
2643
East Asian (EAS)
AF:
0.00
AC:
0
AN:
3515
South Asian (SAS)
AF:
0.000381
AC:
1
AN:
2626
European-Finnish (FIN)
AF:
0.000340
AC:
2
AN:
5875
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
214
European-Non Finnish (NFE)
AF:
0.00193
AC:
102
AN:
52929
Other (OTH)
AF:
0.00331
AC:
5
AN:
1511
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.498
Heterozygous variant carriers
0
5
10
16
21
26
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00142
Hom.:
13
Bravo
AF:
0.00116

ClinVar

ClinVar submissions
Significance:Benign/Likely benign
Revision:criteria provided, multiple submitters, no conflicts
View on ClinVar
Pathogenic
VUS
Benign
Condition
-
-
2
Wiskott-Aldrich syndrome;C1839163:Thrombocytopenia 1;C1845987:X-linked severe congenital neutropenia (2)
-
-
1
not provided (1)
-
-
1
not specified (1)
-
-
1
Wiskott-Aldrich syndrome (1)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.88
CADD
Benign
4.8
DANN
Benign
0.56
PhyloP100
0.33
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs200543049; hg19: chrX-48547839; API